To date, briquilimab has a demonstrated efficacy and safety profile in more than 160 dosed participants and healthy ...

Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 – – Data from the Phase 2a Trial of SLS009 in ...

(Courtesy of Texas Children's Hospital) At Texas Children's Hospital, Fivecoat's daughter Shelly McAfee and her husband Tyler ...

Veteran NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year, the National Basketball Referees ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

In August, Syros discontinued enrollment in the Phase II SELECT-AML-1 trial, in which it was evaluating a triplet regimen of tamibarotene with venetoclax and azacitidine in newly diagnosed, unfit ...

Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.

Syros Pharmaceuticals' Phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome did not meet primary endpoints, ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Cullgen is also evaluating CG009301, a GSPT1 degrader for the treatment of blood cancers including relapsed/refractory acute myeloid leukemia (AML), higher-risk myelodysplastic syndrome (HR-MDS), and ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

My experience with blood cancer began in June 2018 when I had a bone marrow biopsy to determine why my white blood cell count ...